TRAP is a osteoclast specific marker that directly reflects bone resorption activity
Available evidence suggests AHK-Cu is well tolerated with topical application
That is a genetic-knockdown study in mice, not a drug trial: it tells you the target is real and metabolically meaningful in an animal model, but it does not test a drug, a dose, or a route
Some start weekly for a short period, then move to every two to four weeks
The AOD 9604 Treatment Process AOD 9604 is typically administered through subcutaneous injection, which can be performed in our comfortable, serene medical spa environment
This is why its so important to share your full health history, including any supplements you take, with your provider